Manufacturer record
Zoic Biotech Pvt .Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Zoic Biotech Pvt .Ltd (Punjab) were declared Not of Standard Quality between December 2024 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
8 records linked to Zoic Biotech Pvt .Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro Resistant Tablets IP 40 mg | ZTC-165Mfg 2025-03 · Exp 2027-02 | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab | Jun 2026 |
| Esomeprazole Tablets IP | ZTF-037AMfg 2025-06 · Exp 2027-05 | The sample fails the test 'Dissolution' as per IPDissolution | DTL KonniState lab | Apr 2026 |
| Telmisartan & Amlodipine Tablets IP | ZTF-058AMfg 2025-06 · Exp 2027-05 | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Jan 2026 |
| Pdzole -40 Tablets Pantoprazole Gastro Resistant Tablets IP 40 mg | ZBT-7770Mfg 2024-09 · Exp 2026-07 | sample does not conform as per I.P. 2022 with respect to the test for "Dissolution in Buffer Stage" for Pantoprazole.Dissolution | RDTL, GuwahatiCDSCO lab | Sep 2025 |
| AZEN-20 Rabeprazole Tablets IP | ZTL-157Mfg 2024-12 · Exp 2026-11 | sample does not conform to IP with respect to test for Dissolution Acid Stage and Dissolution Buffer Stage.Dissolution | CDL, KolkataCDSCO lab | Sep 2025 |
| Tacrolimus ointment 0.1% w/w | L-014Mfg 2024-12 · Exp 2026-11 | Assay of TacrolimusAssay | RDTL, ChandigarhCDSCO lab | Aug 2025 |
| Ondansetron Orally Disintegrating Tablets IP | ZTF-049AMfg 2025-06 · Exp 2027-05 | DisintegrationDisintegration | RDTL, ChandigarhCDSCO lab | Aug 2025 |
| Esilac Soluion | ZBL-1154Mfg 2023-12 · Exp 2025-11 | Sample does not conform to USP Specification for Lactulose Solution with respect to the Content of Lactulose in Lactulose Concentrate.Other | DTL ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.